- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03121937
Feasibility of a Technology-Based Treatment Support System
October 8, 2018 updated by: Stephen Schueller, Northwestern University
This study aims to evaluate a technology-based treatment support system for patients undergoing the treatment of depression.
The investigators will explore the usefulness of the technology-based treatment support system as an adjunct to psychotherapy for depression.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
This study aims to evaluate a technology-based treatment support system "mConnect" for patients undergoing the treatment of depression.
This system will be evaluated by conducting a randomized controlled trial where patients will either receive the mConnect mobile app or treatment as usual.
Study Type
Interventional
Enrollment (Actual)
11
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Arlington Heights, Illinois, United States, 60004
- AMITA Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years of age or older
- English-speaking
- Currently enrolled in outpatient treatment
- Current diagnosis of major depressive disorder
- Ownership of a smartphone device compatible with the mobile app
Exclusion Criteria
- visual, hearing, voice, or motor impairment that would prevent completion of the study procedures or use of mobile phone
- diagnosis of a psychotic disorder, bipolar disorder, dissociative disorder, substance use disorder, or other diagnosis for which participation in this trial is inappropriate, severe suicidality (has ideation, plan, and intent).
- having completed more than 3 sessions of psychotherapy with current therapist
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mobile App
Participants will receive a mobile app to be used during psychotherapy that syncs information with the participant's therapist from sessions.
|
The mobile app "mConnect" is an app designed to facilitate psychotherapy for depression and includes mood tracking, goal setting, and communication
|
|
No Intervention: Treatment as Usual
Participants will receive treatment as usual with aspects of the mobile app available through paper-based worksheets.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retention
Time Frame: 8 weeks
|
Number of completed sessions
|
8 weeks
|
|
Adherence
Time Frame: 8 weeks
|
The use of the mobile app.
This data will be collected passively by the mobile app sending the following information to the secure server: the date and time the mobile app is launched, the date and time any information is entered into the mobile app, the content of any information entered into the mobile app, the date and time any lessons within the mobile app are read by the participant.
|
8 weeks
|
|
Satisfaction
Time Frame: 8 weeks
|
Participant satisfaction with the mobile app will be assessed with a patient version of the Mobile App Rating Scale (MARS) that addresses engagement, functionality, aesthestics, information quality, and one subjective rating of the app as a whole.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression
Time Frame: 8 weeks
|
Depression as measured by the PHQ-9
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Stephen M Schueller, PhD, Northwestern University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2017
Primary Completion (Actual)
June 30, 2018
Study Completion (Actual)
June 30, 2018
Study Registration Dates
First Submitted
April 11, 2017
First Submitted That Met QC Criteria
April 17, 2017
First Posted (Actual)
April 20, 2017
Study Record Updates
Last Update Posted (Actual)
October 10, 2018
Last Update Submitted That Met QC Criteria
October 8, 2018
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00097492
- K08MH102336 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.